Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

133 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Diabetes mellitus: a hypercoagulable state.
Carr ME. Carr ME. J Diabetes Complications. 2001 Jan-Feb;15(1):44-54. doi: 10.1016/s1056-8727(00)00132-x. J Diabetes Complications. 2001. PMID: 11259926 Review.
The effect of uremia on platelet contractile force, clot elastic modulus and bleeding time in hemodialysis patients.
Brophy DF, Martin EJ, Carr SL, Kirschbaum B, Carr ME Jr. Brophy DF, et al. Among authors: carr sl, carr me jr. Thromb Res. 2007;119(6):723-9. doi: 10.1016/j.thromres.2006.02.013. Epub 2006 Jun 21. Thromb Res. 2007. PMID: 16793120
A hypothesis-generating study to evaluate platelet activity in diabetics with chronic kidney disease.
Brophy DF, Martin RJ, Gehr TW, Carr ME Jr. Brophy DF, et al. Among authors: carr me jr. Thromb J. 2005 Mar 29;3(1):3. doi: 10.1186/1477-9560-3-3. Thromb J. 2005. PMID: 15796773 Free PMC article.
Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood.
Carr ME Jr, Angchaisuksiri P, Carr SL, Martin EJ. Carr ME Jr, et al. Among authors: carr sl. Cell Biochem Biophys. 2003;39(2):89-99. doi: 10.1385/CBB:39:2:89. Cell Biochem Biophys. 2003. PMID: 14515016
Development of platelet contractile force as a research and clinical measure of platelet function.
Carr ME Jr. Carr ME Jr. Cell Biochem Biophys. 2003;38(1):55-78. doi: 10.1385/CBB:38:1:55. Cell Biochem Biophys. 2003. PMID: 12663942 Review.
Aprotinin counteracts heparin-induced inhibition of platelet contractile force.
Carr ME Jr, Carr SL, Roa V, McCardell KA, Greilich PE. Carr ME Jr, et al. Among authors: carr sl. Thromb Res. 2002 Nov 1;108(2-3):161-8. doi: 10.1016/s0049-3848(02)00403-6. Thromb Res. 2002. PMID: 12590953
Enhanced platelet force development despite drug-induced inhibition of platelet aggregation in patients with thromboangiitis obliterans--two case reports.
Carr ME Jr, Hackney MH, Hines SJ, Heddinger SP, Carr SL, Martin EJ. Carr ME Jr, et al. Among authors: carr sl. Vasc Endovascular Surg. 2002 Nov-Dec;36(6):473-80. doi: 10.1177/153857440203600610. Vasc Endovascular Surg. 2002. PMID: 12476239
Patients with coronary artery disease who present with chest pain have significantly elevated platelet contractile force and clot elastic modulus.
Krishnaswami A, Carr ME Jr, Jesse RL, Kontos MC, Minisi AJ, Ornato JP, Vetrovec GW, Martin EJ. Krishnaswami A, et al. Among authors: carr me jr. Thromb Haemost. 2002 Nov;88(5):739-44. Thromb Haemost. 2002. PMID: 12428087
Evolving techniques for monitoring clotting in plasma and whole blood samples.
Carr ME Jr, Martin EJ. Carr ME Jr, et al. Clin Lab. 2004;50(9-10):539-49. Clin Lab. 2004. PMID: 15481629 Review.
Enhanced anticoagulant activity of enoxaparin in patients with ESRD as measured by thrombin generation time.
Brophy DF, Martin EJ, Gehr TW, Carr ME Jr. Brophy DF, et al. Among authors: carr me jr. Am J Kidney Dis. 2004 Aug;44(2):270-7. doi: 10.1053/j.ajkd.2004.04.032. Am J Kidney Dis. 2004. PMID: 15264185
133 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback